AlphaStar Capital Management LLC purchased a new position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 23,139 shares of the company’s stock, valued at approximately $878,000.
A number of other hedge funds have also bought and sold shares of BME. International Assets Investment Management LLC bought a new position in shares of BlackRock Health Sciences Trust during the third quarter valued at approximately $8,610,000. Janney Montgomery Scott LLC grew its stake in BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after buying an additional 9,455 shares during the last quarter. Fountainhead AM LLC bought a new stake in BlackRock Health Sciences Trust in the third quarter valued at $204,000. Consolidated Portfolio Review Corp boosted its holdings in shares of BlackRock Health Sciences Trust by 7.2% during the third quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock valued at $1,785,000 after acquiring an additional 2,853 shares during the period. Finally, Wolverine Asset Management LLC grew its position in shares of BlackRock Health Sciences Trust by 42.4% during the third quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock worth $3,588,000 after acquiring an additional 25,457 shares during the last quarter.
BlackRock Health Sciences Trust Trading Down 0.2 %
Shares of NYSE:BME opened at $40.64 on Friday. The company’s 50-day moving average price is $39.17 and its 200 day moving average price is $40.46. BlackRock Health Sciences Trust has a fifty-two week low of $36.87 and a fifty-two week high of $42.75.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- How Investors Can Find the Best Cheap Dividend Stocks
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.